General Sessions

General Sessions at a Glance

Thursday, January 22nd, 2009 - Day One

7:00

Conference Registration & Morning Coffee in Exhibit Hall
Registration hosted by

Brookwood Pharmaceuticals Genzyme Logo

8:00

Co-Chairperson’s Welcome & Opening Remarks

Peter B. Kramer, PhD
Executive Director, External Science & Technology, Strategic Transactions Group, Bristol-Myers Squibb

Vik Seoni
Vice President, Business Development, Endo Pharmaceuticals

8:15

2009 Drug Delivery Industry Update An Interactive Panel with Drug Delivery Business Experts

Debra Bingham
Partner, Valeo Partners

Panelists:
Peter Thornton
SVP, Head of Product, Technology and Business Development, Elan Drug Technologies

John J. Fraher
Chief Commercial Officer, Eurand

Anthony N. Cacich
Vice President & General Manager, Contract Manufacturing Services, Hospira Worldwide, Inc., One 2 One® Global Pharmaceutical Services

9:00

Annual Wall Street Address: Sector Trends, Key Products & Technologies to Watch, and Predictions for the Future

David M. Steinberg
Managing Director, Equity Research, Specialty Pharmaceuticals and Drug Delivery, Deutsche Bank

9:30

Panel Discussion VC & Private Equity Panel – How Do You Look for the Next Big Investment Prospect?

Moderator:
David M. Steinberg
Managing Director, Equity Research, Specialty Pharma and Drug Delivery, Deutsche Bank

Panelists:


David Neustaedter, PhD, MBA,

Director, Covidien Ventures

Art Pappas
Managing Director, Pappas Ventures

Robert More
Partner, Frazier

Brett Zbar
Partner, Aisling Capital

10:00Networking Business Exchange in Exhibit Hall
10:45

Keynote Presentation: Innovation in Science & Technology: A Critical Path to Addressing Global Health Inequities

Dr. Steven Buchsbaum
Deputy Director Discover Strategy, Bill & Melinda Gates Foundation

11:30

Keynote Presentation: Open Business Models – How to Thrive in the New Innovation Landscape

Henry Chesbrough, PhD
Professor & Executive Director, Center for Open Innovation, Haas School of Business, University of California-Berkeley and Author

12:15

Networking Luncheon in Exhibit Hall,
Hosted by

Catalent Logo

1:45Afternoon Tracks Begin

Download Brochure for Full Session Details // View Day One Breakout Tracks

Friday, January 23rd, 2009 - Day Two

7:30Morning Coffee in Exhibit Hall
8:00

Co-Chair’s Opening Remarks

Peter B. Kramer, PhD
Executive Director, External Science & Technology, Strategic Transactions Group, Bristol-Myers Squibb

Vik Seoni
Vice President, Business Development, Endo Pharmaceuticals

8:15

Keynote Presentation: Building Brand Equity: Drug Delivery & the Mucinex Story

Bob Casale
Former Chief Operating Officer, Adams Respiratory Therapeutics

9:00

Panel Discussion Where Does the Future Lie for Systemic Delivery of Drugs by Inhalation?

Moderator:
Martin E. Judge, PhD
Sourcing Director, Diabetes Research Unit, Novo Nordisk A/S

Panelists:
Alfred E. Mann
Chairman and Chief Executive Officer, Mannkind Corporation

Igor Gonda
President & Chief Executive Officer, Aradigm Corporation

John Patton
Chief Research Fellow, Nektar

9:45Networking Business Exchange in Exhibit Hall
10:30

Panel Discussion How Will Novel Drug Delivery Technologies Serve to Address Issues Surrounding Abuse of Pain Products?

Moderator:
Allen Downs
Senior Executive Director, Licensing & Business Development, Purdue Pharmaceuticals

Panelists:
Shawn A. Scranton
PharmD, Vice President, Scientific Operations, Victory Pharma, Inc.

Anand R. Baichwal, PhD
SVP Licensing & CSO, Penwest Pharmaceuticals

Vik Seoni
Vice President, Business Development, Endo Pharmaceuticals

John Taylor
Vice President, Business Development, Javelin Pharmaceuticals, Inc.

Robert Bloder
Vice President, Business Development, Aveva Drug Delivery Systems

11:15

Keynote Presentation: How to Compete in a Global Economy

Todd Buchholz
Former White House Director of Economic Policy and Author, New Ideas From Dead CEOs

12:15Networking Luncheon in Exhibit Hall
1:30Afternoon Tracks Begin

Download Brochure for Full Session Details // View Day Two Breakout Tracks

Brochure Register Press Policy Recommend Contact Opt-in Home
© 2008-2009 IIR Holdings, LTD. All Rights Reserved.